Related Experiment Video
Updated: Jul 7, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
[Prevention of erectile dysfunction in patients with metabolic syndrome]
Abstract:
The aim of the study was to test efficacy of erectile dysfunction prevention in patients with metabolic syndrome by correction of metabolic disorders and stimulation of endothelial NO-synthetase. In case of the above correction and stimulation combination, the risk of erectile dysfunction went up significantly compared to placebo group and patients with correction of metabolic disorders alone.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Coronary Artery Disease I: Introduction
Oral Hypoglycemic Agents: Biguanides and Glitazones